Physician profile
Michael D Eifling
NPI 1295921989
$316,665.39
in general payments reported to CMS, 2019-2025
25 companies · $29K in 2025
The $29K reported for 2025 was more than what 92% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $7,502 · 2021: $20K · 2022: $16K · 2023: $100K · 2024: $87K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $158K · Travel and Lodging: $33K · Food and Beverage: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,500 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $157,700.00 |
| Travel and Lodging | $32,670.73 |
| Food and Beverage | $13,574.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,500.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $223,628.94 | 2019-2025 | Amplatzer Amulet, Amplatzer Piccolo, Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $63,529.25 | 2019-2023 | Xarelto |
| Medtronic Vascular, INC. | $8,431.95 | 2019-2020 | |
| Atricure, INC. | $8,074.17 | 2019-2021 | |
| Biosense Webster, INC. | $6,969.93 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Medtronic, INC. | $2,748.21 | 2021-2025 | Micra, Selectsecure, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $1,981.81 | 2019-2025 | Bodyguardian, Emblem Mri S-Icd, Ingevity Mri |
| E.R. Squibb & Sons, L.L.C. | $281.01 | 2022-2024 | Camzyos |
| Cardiofocus, INC. | $176.37 | 2019 | |
| Pfizer INC. | $164.56 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $150.95 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $95.97 | 2023-2024 | |
| Bardy Diagnostics, INC. | $74.49 | 2019-2022 | |
| Biotronik INC. | $62.72 | 2019-2022 | |
| Abiomed | $42.42 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.40 | 2023 | Jardiance |
| Cvrx, INC. | $40.20 | 2022 | |
| Novo Nordisk INC | $31.40 | 2025 | Wegovy |
| Daiichi Sankyo INC. | $27.88 | 2023 | Injectafer |
| Alnylam Pharmaceuticals INC. | $22.91 | 2024 | Onpattro |
| Altathera Pharmaceuticals LLC | $22.16 | 2024 | Sotalol Hydrochloride |
| Cardiva Medical, INC. | $20.42 | 2019 | |
| Convatec INC. | $17.55 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.82 | 2021 | |
| Esperion Therapeutics, INC. | $12.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Eifling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.